Screening for cardiac amyloidosis in patients with newly identified conduction disease
Not Applicable
Not yet recruiting
- Conditions
- Cardiac amylodiosisCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12624000520538
- Lead Sponsor
- Box Hill Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Patients 65 or older who have new conduction disease requiring the implantation of a pacemaker.
Exclusion Criteria
–Known cardiac amyloidosis.
–Patients with a clear alternative cause of conduction disease including other infiltrative cardiomyopathies, ischaemia or medication induced conduction disease.
–Patients with life expectancy < 12 months or severe comorbidities where screening would not be beneficial for the individual.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method